InvestorsHub Logo
Followers 135
Posts 9915
Boards Moderated 1
Alias Born 03/20/2013

Re: MoneyGrubber13 post# 4771

Sunday, 01/26/2020 8:16:29 AM

Sunday, January 26, 2020 8:16:29 AM

Post# of 7492

......there are over 2 million people in Japan with vitiligo, which seems to be an enormous market opportunity compared to the U.S. In summary, total # of sales of RECELL kits for treatment of vitiligo in Japan could be enormous compared to the U.S.




Doesn't that beg the question:

How available will the procedure be for vitiligo sufferers?

I'm thinking not only of insurability depth but also medical people trained and/or otherwise prepared to train so as to be positioned to offer ReCell to patients? We know of the advantages Avita offers here in the States but medical breakthroughs do take time to develop pathways in terms of commercialization. I'd expect the process to require a couple of years in that other country.

I know nothing about Japan's medical insurance system so all information will be most appreciated. Being a senior and a recipient of Medicare coverage, I can't help but wonder about vitiligo itself. A year ago I wouldn't have known it as a disease, so ignorant was I. Today, I know of it as a pigment condition people find unacceptable. Does that, alone, translate into insurability likely to cover a patient's wish to be free of an unsightly disorder? Perhaps I should point out that seven years ago I was told I'd be dead in a year or less due to a cancer onset unless immediate action was taken. Several years post-op I was pronounced cancer free, thankfully. Medicare paid for everything other than for a $52.40 bill I delightedly paid myself. Our medical insurance program here is awesome. But I don't think Medicare would pay for cosmetic surgery. However, I have no knowledge of such issues.

Thank you!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RCEL News